215 related articles for article (PubMed ID: 29169616)
21. Clinical outcome for MCTs of canine pinnae treated with surgical excision (2004-2008).
Schwab TM; Popovitch C; DeBiasio J; Goldschmidt M
J Am Anim Hosp Assoc; 2014; 50(3):187-91. PubMed ID: 24659731
[TBL] [Abstract][Full Text] [Related]
22. Second intention healing after wide local excision of soft tissue sarcomas in the distal aspects of the limbs in dogs: 31 cases (2005-2012).
Prpich CY; Santamaria AC; Simcock JO; Wong HK; Nimmo JS; Kuntz CA
J Am Vet Med Assoc; 2014 Jan; 244(2):187-94. PubMed ID: 24378028
[TBL] [Abstract][Full Text] [Related]
23. Association of argyrophilic nucleolar organizing regions, Ki-67, and proliferating cell nuclear antigen scores with histologic grade and survival in dogs with soft tissue sarcomas: 60 cases (1996-2002).
Ettinger SN; Scase TJ; Oberthaler KT; Craft DM; McKnight JA; Leibman NF; Charney SC; Bergman PJ
J Am Vet Med Assoc; 2006 Apr; 228(7):1053-62. PubMed ID: 16579784
[TBL] [Abstract][Full Text] [Related]
24. Variability in tumor margin reporting for soft tissue sarcoma and cutaneous mast cell tumors in dogs: A systematic review.
Abrams BE; Putterman AB; Ruple A; Wavreille V; Selmic LE
Vet Surg; 2021 Feb; 50(2):259-272. PubMed ID: 33331059
[TBL] [Abstract][Full Text] [Related]
25. Unclassified sarcomas: a study to improve classification in a cohort of Golden Retriever dogs.
Boerkamp KM; Hellmén E; Willén H; Grinwis GC; Teske E; Rutteman GR
J Vet Diagn Invest; 2016 Nov; 28(6):623-631. PubMed ID: 27698172
[TBL] [Abstract][Full Text] [Related]
26. Grade shifts in recurrent canine soft tissue sarcomas and mast cell tumors.
Griffin MA; Hughes K; Altwal J; Seguin B; Wustefeld-Janssens B
J Am Vet Med Assoc; 2023 Sep; 261(9):1-8. PubMed ID: 37257826
[TBL] [Abstract][Full Text] [Related]
27. Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.
Giantin M; Aresu L; Benali S; Aricò A; Morello EM; Martano M; Vascellari M; Castagnaro M; Lopparelli RM; Zancanella V; Granato A; Mutinelli F; Dacasto M
J Comp Pathol; 2012 Nov; 147(4):419-29. PubMed ID: 22520817
[TBL] [Abstract][Full Text] [Related]
28. Narrative operative reports inconsistently record surgical information relating to resection of soft tissue sarcomas and mast cell tumors in dogs.
O'Neill M; Wustefeld-Janssens BG; Tremolada G; Griffin M
J Am Vet Med Assoc; 2023 Oct; 261(10):1-5. PubMed ID: 37290758
[TBL] [Abstract][Full Text] [Related]
29. Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.
Northrup NC; Harmon BG; Gieger TL; Brown CA; Carmichael KP; Garcia A; Latimer KS; Munday JS; Rakich PM; Richey LJ; Stedman NL; Cheng AL; Howerth EW
J Vet Diagn Invest; 2005 May; 17(3):245-8. PubMed ID: 15945380
[TBL] [Abstract][Full Text] [Related]
30. Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study.
Paulos PE; Boston S; Skinner OT; Liptak JM; Amsellem PM; Fournier Q; Wood CJ; Annoni M; Murgia D; Oblak ML; Dean BL; Baird SD; Kulendra NJ
Vet Comp Oncol; 2022 Sep; 20(3):669-678. PubMed ID: 35420253
[TBL] [Abstract][Full Text] [Related]
31. Soft-tissue sarcomas in dogs: a review.
Ehrhart N
J Am Anim Hosp Assoc; 2005; 41(4):241-6. PubMed ID: 15995161
[TBL] [Abstract][Full Text] [Related]
32. Intra-operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography.
Selmic LE; Samuelson J; Reagan JK; Mesa KJ; Driskell E; Li J; Marjanovic M; Boppart SA
Vet Comp Oncol; 2019 Mar; 17(1):80-88. PubMed ID: 30239117
[TBL] [Abstract][Full Text] [Related]
33. Scar revision for incompletely or narrowly excised soft tissue sarcomas in dogs.
Grimes JA; Rajeev M; Wallace ML; Laver T; Milovancev M
Can Vet J; 2023 Jan; 64(1):70-75. PubMed ID: 36593932
[TBL] [Abstract][Full Text] [Related]
34. Histologic grade predicts recurrence for marginally excised canine subcutaneous soft tissue sarcomas.
McSporran KD
Vet Pathol; 2009 Sep; 46(5):928-33. PubMed ID: 19429989
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors for cutaneous and subcutaneous soft tissue sarcomas in dogs.
Dennis MM; McSporran KD; Bacon NJ; Schulman FY; Foster RA; Powers BE
Vet Pathol; 2011 Jan; 48(1):73-84. PubMed ID: 21139143
[TBL] [Abstract][Full Text] [Related]
36. The use of KIT and tryptase expression patterns as prognostic tools for canine cutaneous mast cell tumors.
Kiupel M; Webster JD; Kaneene JB; Miller R; Yuzbasiyan-Gurkan V
Vet Pathol; 2004 Jul; 41(4):371-7. PubMed ID: 15232137
[TBL] [Abstract][Full Text] [Related]
37. A retrospective comparison of carbon dioxide surgical laser and non-laser excision for removal of cutaneous and subcutaneous soft-tissue sarcomas in dogs.
Agulian L; Mann FA; Middleton JR; Kim DY
N Z Vet J; 2020 Nov; 68(6):340-344. PubMed ID: 32529958
[No Abstract] [Full Text] [Related]
38. Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.
Monteiro B; Boston S; Monteith G
Can Vet J; 2011 Nov; 52(11):1209-14. PubMed ID: 22547841
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).
Bacon NJ; Dernell WS; Ehrhart N; Powers BE; Withrow SJ
J Am Vet Med Assoc; 2007 Feb; 230(4):548-54. PubMed ID: 17302554
[TBL] [Abstract][Full Text] [Related]
40. Expression of Fibroblast Activating Protein and Correlation with Histological Grade, Mitotic Index and Ki67 Expression in Canine Mast Cell Tumours.
Giuliano A; Dos Santos Horta R; Constantino-Casas F; Hoather T; Dobson J
J Comp Pathol; 2017 Jan; 156(1):14-20. PubMed ID: 27889201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
